BrainsWay (BrainsWay) Other Long-Term Liabilities : $5.84 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is BrainsWay Other Long-Term Liabilities?

BrainsWay's other long-term liabilities for the quarter that ended in Mar. 2024 was $5.84 Mil.

BrainsWay's quarterly other long-term liabilities increased from Sep. 2023 ($5.37 Mil) to Dec. 2023 ($6.08 Mil) but then declined from Dec. 2023 ($6.08 Mil) to Mar. 2024 ($5.84 Mil).

BrainsWay's annual other long-term liabilities increased from Dec. 2021 ($5.93 Mil) to Dec. 2022 ($6.02 Mil) and increased from Dec. 2022 ($6.02 Mil) to Dec. 2023 ($6.08 Mil).

BrainsWay Other Long-Term Liabilities Historical Data

The historical data trend for BrainsWay's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrainsWay Other Long-Term Liabilities Chart

BrainsWay Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

BrainsWay Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

BrainsWay Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

BrainsWay Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of BrainsWay's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

BrainsWay (BrainsWay) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BrainsWay Ltd (NAS:BWAY) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

BWAY:Israel

Address

19 Hartum Street, 3rd Floor, Bynet Building, Har Hotzvim, Jerusalem, ISR, 9777518

Website

https://www.brainsway.com

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.